key: cord-0929969-cnbasfz5
authors: Djulbegovic, Benjamin; Hozo, Iztok; Guyatt, Gordon
title: Evidence, values & masks for control of COVID-19
date: 2020-12-01
journal: J Clin Epidemiol
DOI: 10.1016/j.jclinepi.2020.11.020
sha: 5160b966a2eb8c27db404a03038390a13ec6e21c
doc_id: 929969
cord_uid: cnbasfz5

nan

interests. Public health decisions are paradigmatic of this tension. In 1902, during a smallpox epidemic in state of Massachusetts, Reverend Henning Jacobson refused to receive vaccination against smallpox. 1 He invoked his individual rights against "arbitrary and oppressive" laws, his religious beliefs, concerns about civil liberties and safety records of the vaccines (apparently he and his son had had serious adverse reactions to earlier vaccinations). In 1905, the US Supreme Court ruled that Board of Health Authority of Massachusetts had the right to require vaccination against smallpox during a smallpox epidemic. 1 The threat to the group was simply too large to accommodate personal beliefs.

In 1918, the influenza pandemic devastated the United States. Masks, typically made of gauze and cheesecloth, were the only recourse against the spread of the deadly virus. But, then, as now, during the current COVID-19 pandemic, some people resisted wearing masks, perceiving direction to do so as a threat to personal liberty. 2 Here we argue that the tension between public and individual values, while inevitable, can be substantially reduced by clear communication of evidence -even imperfect evidence. In fact, perfect evidence indicating the absolute "truth" is theoretically impossible. 3 Nevertheless, in the best tradition of evidence-based medicine, evidence can narrow difference between competing views. 4 It may even be that varying understanding of the evidence might explain alternative positions that appear to be driven by value differences. 5 For instance, some who advocate for legislated enforcement of mask use may temper their position if they are aware that risks of infection are extremely low even without mask use; those resisting mask use may temper their position if they believe mask use will result in an important reduction in risks to themselves and their loved ones. Knowing evidence-with all associated uncertainties-can narrow gaps in our disagreements seemingly driven by incompatible values. 5

We focus on the effects of masks -possibly one of the most important yet controversial tools currently available for controlling the COVID-19 pandemic. Evidence on efficacy of masks for prevention of COVID19 is based on observational studies and were rated as "low certainty" by the authors of most comprehensive systematic review on the topic to date. 6 However, the authors also stated: "The effect was very large [adjusted odds ratio (OR): 0.15; 95%CI: 0.07 to 0.34); unadjusted relative risk (RR): 0.34; 95%CI: 0.26 to 0.45] , and the certainty of evidence could be rated up, but we made a conservative decision not to because of some inconsistency and risk of bias; hence, although the effect is qualitatively highly certain, the precise quantitative effect is low certainty." 6 The authors are making the point that when the effect size is very large (say relative risk reduction over 50%), such an effect can typically override combined effected of random error and biases. 7-9 Therefore, even though existing evidence is insufficient to be certain of the magnitude of benefit, we can be confident that these interventions do result in some reduction in coronavirus transmission. 6 10,11 The effect is likely magnified when wearing masks is combined with physical distancing; evidence for latter is judged to be of moderate certainty. 6 Because it is not known if the combined effects of masks and physical distancing are dependent or independent, additive or multiplicative, in this paper we focus only on the effect of masks on prevention of COVID19 cases and deaths. Thus, results shown represent minimal projected effects -they may be much larger. Even so, results appear convincing regarding the acceptable course of action.

We first start with highlighting an important but often not fully appreciated fact: different communities have widely varying incidence and prevalence of COVID-19. The impact of SARS-CoV-2 virus on morbidity and mortality will be vastly different between high vs low prevalence jurisdictions.

As a consequence, in low prevalence areas, we might be appropriately more tolerant of individuals electing not to adopt personal protection: failure to do so is unlikely to affect others.

For example, the estimate in Oslo, Norway in May of 2020 put the infection rate at 10 cases per 100,000 people per week. 12 This would mean to prevent 6 COVID-19 cases/week, 1 million people would need to wear facemasks. 12 The authors of the report documenting the risk judged it too low to warrant imposing the burden of universal mask implementation. 12 To illustrate the potential impact of prevalence on COVID-19 in the US, we estimated effects of masks across the US counties included in the New York Times database using data on the effectiveness of masks cited earlier. 6 Taking a public health perspective on mask wearing, we estimated the impact of different compliance rates of wearing masks on COVID-19 infection and mortality. However, New York City, which was the leading COVID19 "hot spot" in the US until August 2020 has now been overtaken by Winnebago, WI as the county with the highest percentage of cases and deaths due to COVID19. Figure 2 shows that by October 22, 2020 SARS-CoV-2 virus has substantially covered the entire continental US. Thus, the lower risk areas which may at one time have warranted lower vigilance, may no longer do so.

When the tradeoff between benefits and harms of a given intervention are uncertain, as is the case for the clinical and public health interventions and their associated social and economic costs for COVID-19, comparing the effects to some commonly accepted benchmarks may aid decision-making. Comparing the NNT for wearing masks (number of people who would need to wear the mask to prevent one COVID-19 infection or death, on average) with NNTs of commonly accepted medical interventions may provide guidance. Table 1 shows NNT for a number of widely accepted medical treatments compared with no interventions when there existed a low risk of serious adverse outcomes without treatment. The NNTs ranges from 36 (β− blockers for treatment of congestive heart failure) to 500 (statins for primary prevention of heart disease). 13 Given that millions of people routinely use statins, it is reasonable to suggest NNT of 500 as a reference point below which most people would accept intervention for low frequency event. In our analysis, performed on October 22, 2020, almost 95% (561/591) of counties that have at least 30 days of reported data with over 100,000 population had a prevalence that converts into NNT≤ 500 for the effects of masks on preventing a new case of COVID-19. If this metrics is used for all (n=3103) continental US counties (Fig 2) 16 We conclude that the debate about wearing masks and observing physical distancing suffers from an insufficiently clear presentation of the evidence regarding the impact of these interventions on morbidity and mortality due to COVID-19. A focus on the evidence, along with encouragement to reflect on the implications, could potentially reduce the extent, or at least the intensity, of differences between opposing parties. Moreover, a focus on the evidence would improve the quality of decisions by those charged with balancing issues of safeguarding the health of the community versus individual autonomy. green (substantial risk) 4 to 7 cases/day/100,000 people (61 to 105 cases/15 days/100,000) (59 counties); blue (widespread risk) >7 cases/day/100,000 people split here in two categories high risk: 105 to 300 cases/15 days/100,000) (530 counties); and 300 to 32,000 cases/15 days/100,000) (2484 counties). White: presumably no data or no cases were reported in NYT database as of October 21, 2020) *modified from ref #13 (restricted to placebo or no treatment as a comparator); **only counties (n=596) with a population of at least 100,000 and a history of at least 30 days of reported data were considered (calculation refers to the assessment performed on Oct 22, 2020); *** all risk refers to what is considered a low risk of developing outcome without treatment; ****unless otherwise specified, outcomes refer to 1 year time frame; # during 5 years of treatment. Note that we restricted analyses to common and non-controversial treatments. Some interventions in wide use such as use of screening mammography have NNT>500 but they are not without controversy. 

Jacobson v Massachusetts: it's not your great-greatgrandfather's public health law

The Mask Slackers of 1918

When Should Potentially False Research Findings Be Considered Acceptable?

Epistemologic inquiries in evidence-based medicine

The cost-benefit revolution

Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. The Lancet

US Food and Drug Administration Approvals of Drugs and Devices Based on Nonrandomized Clinical Trials: A Systematic Review and Meta-analysisDrug and Device Approvals Based on Nonrandomized Clinical TrialsDrug and Device Approvals Based on Nonrandomized Clinical Trials

Larger effect sizes in nonrandomized studies are associated with higher rates of EMA licensing approval

When are randomised trials unnecessary? Picking signal from noise

Association Between Universal Masking in a Health Care System and SARS-CoV-2 Positivity Among Health Care Workers

Universal Masking to Prevent SARS-CoV-2 Transmission-The Time Is Now

COVID-19: Should individuals in the community without respiratory symptoms wear facemasks to reduce the spread of COVID-19? [Covid-19: Bør personer i samfunnet bruke ansiktsmasker for å redusere spredningen av covid-19? Hurtigoversikt

Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice

Blueprint for a Safer Economy

Universal Masking in the United States: The Role of Mandates, Health Education, and the CDC

Two metres or one: what is the evidence for physical distancing in covid-19?

BD and GG conceptualized paper; IH developed statistical codes. BD wrote the first draft, which was revised and approved by all authors.Ethics, to the large extent, represents navigating group and societal with individual and personal interests.During COVID19 pandemics some people resisted wearing masks, perceiving direction to do so as a threat to personal liberty When the tradeoff between benefits and harms of a given intervention are uncertain comparing the effects to some commonly accepted benchmarks may aid decision-making Given that millions of people routinely use statins, it is reasonable to suggest NNT of 500 as a reference point below which most people would accept intervention for low frequency event Based on NNT=500 as a reference point, we calculated that people living in 96% (3103) counties in the continental US would readily accept wearing masks.